ARCHIVES

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 33 No. 29 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

Workshop Suggests Confirmation of Vitamin C Studies

December 7, 1990

NCAB Committee Agrees On Seven Characteristics For Comprehensive Centers, Asks For New Division

May 12, 1989

Abstracts From AACR Annual Meeting

May 28, 1976

Curt, Ozols, Brown Leaving NCI; More DCT Staff Changes

June 10, 1988

In Brief: ONS, ASCO AACR Meetings Open In St. Louis Next Week; Bristol-Myers Adds Farber, McArdle Grants

April 16, 1982

FDA Puts Clinical Hold On Gene Therapy Trials

January 24, 2003